- About ELS
- Therapeutic Areas
- Operational Metrics
- Contact Us
Dr. Vijai Kumar has over 44 years of experience in Global Drug Development, Strategic Relationship Building, Business Development and various other aspects of clinical research and the pharmaceutical industry.
He is responsible for starting the concept of site management organizations in Asia. Prior to that, Dr. Kumar worked as President and CEO, Neeman Medical International and as Medical Director, Sandoz and Regional Director, Asia for The Upjohn Company, where he was responsible for contributing to more than 25 NDA submissions.
Dr. Kumar has served as a clinician, investigator, pharmaceutical physician, consultant and service provider. He has served as a Member of the expert committee constituted by the Drugs Controller General (India) to develop GCP Guidelines in India and as a member of the Board of Governors for the Institute of Clinical Research, India. Dr Kumar has personally been involved in the conduct of over 200 clinical trials in various therapeutic areas such as, Oncology, Infectious Disease, Neuropsychiatry, Cardiovascular Disorders, Metabolism and Rheumatology, Ophthalmology in Asia, Europe and the USA and has presented numerous papers on various aspects of clinical research across the globe. Dr Kumar holds an M.D. in Internal Medicine and an M.B.B.S. from Armed Forces Medical College, Pune.
Dr. Kumar was recently recognized by an audience of his peers as a most inspiring leader in the drug development and life sciences industry. Dr. Kumar’s long time passion, dedication and contributions to clinical research were highlighted in a special profile within the PharmaVoice Magazine special issue -“100 of the Most Inspiring People”. He was featured in a dedicated profile within the magazine in a section titled “The Clinical Specialists” Dr. Kumar is the Advisory Board member of Life Science World.
Dr. Das has over 25 years of research experience in managing all phases of global and domestic clinical research projects. Prior to joining Excel Life Sciences, Dr. Das was responsible for establishing two major SMOs, one CRO and one major hospital chain in India. He has led large clinical operations team of over 140 clinical research personnel and successfully trained more than 6,000 individuals including Investigators, CRC’s and CRAs’ and other stakeholders including lab and pharmacy personnel, Ethics Committee members. He has organized more than 75 ICH GCP and other clinical research related workshops.
Dr. Das has co-ordinated the setup of one of the largest vaccine studies in Egypt. He managed 30 sites at one time in global trials and has been in charge of the 4 sites and the CRCs which became the first clinical trial sites in India to be inspected by US FDA. Trained and mentored by Harvard Medical Institute USA faculty on Fundamentals of Drug Development, Clinical Research and ICH GCP over multiple sessions from 2001-2003.. Dr. Das has worked on the faculty of the CDSCO, WHO and ICRI. Dr. Das holds an M.D. in clinical pharmacology from M. K. C. G. Medical College in Odisha, India.
Prior to ELS Mohit was the General Manager, New Product and Platforms for American Express where he led a global servicing team based out of the US, Canada and India. Previously, he was the Co-Founder and Interim Chief Executive Officer of Workadia. Before Workadia, Mohit had been at American Express for over 10 years, most recently as Vice President in its Interactive Business Development group, where he was the founding member and business leader for Workadia, which was spun off from within American Express. He played a key role in transforming the corporate travel industry from a manual labor-intensive operation to an online, highly automated and efficient environment.
His experience in leveraging technology and labor arbitrage to reduce operating costs and accelerate product development led him to found Excel Life Sciences, which helps customers accelerate drug development and improve patient care and satisfaction, while lowering the costs for pharmaceutical companies, hospitals and medical research organizations. In addition, Mohit also wants to focus on the humanitarian aspect of bringing leading lines of treatment to a patient population that does not necessarily have access to healthcare. This humanitarian aspect is an integral part of the Excel Life Sciences mission. Mohit holds a Bachelor’s degree in Business from University of Allahabad, India and a Master of Science from the University of Massachusetts, Amherst.
Chris Fallows has more than 20 years’ experience in Life Sciences industry. Prior to joining ELS he spent time in the CRO/SMO space and had significant experience leveraging technology to help advance his customer’s clinical goals. During his time in the industry, he has worked with clients that range from small biotech to large pharma providing solutions that address the specific needs of each organization.
Chris will draw on the depth of his business development expertise in directing the company’s Sales and Marketing initiatives.
In the last 12 years, Carl has been the senior financial executive of a number of tech start-ups, either as the in-house CFO or a consulting CFO. These firms have been in a range of industries from consulting to software to opto-electronics and healthcare. Previously, Carl had spent over ten years in various financial and strategic roles in the US and Europe at Global 100 manufacturing firms.
His roles included merger and acquisition due diligence on several transactions ranging from $10 to $300 million, developing the business case for a number of joint ventures, and subsequently moving two of those joint ventures from start-up to profitability as the financial executive. Carl holds a BA in Economics and an MBA Finance from the University of Illinois.